Amundi Asset Management US’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,200	Closed	-$108K	–	1623
2020 Q1	$108K	Buy	+9,200	New	+$108K	﹤0.01%	1413